Melanoma Surveillance in the US: Melanoma, Ultraviolet Radiation, and Socioeconomic Status

Published Online: Wednesday, September 26, 2012
Follow Pharmacy_Times:
In this podcast from the Centers for Disease Control and Prevention, Chris Johnson, from the Cancer Data Registry of Idaho, discusses the results of several studies published in a supplement to the November 2011 edition of the Journal of the American Academy of Dermatology that examined the relationship between rates of melanoma and 2 variables recorded at the county level: ultraviolet radiation and socioeconomic status.
 
To listen to the podcast, click here.
Related Articles
Celgene today announced that the FDA has granted an expanded use approval for its multiple myeloma drug, lenalidomide (Revlimid).
Although testosterone is often considered to be a catalyst of prostate cancer, a recent study suggests that the hormone may be able to subdue advanced prostate cancer and break down resistance to testosterone-blocking drugs used to treat the disease.
A vaccine therapy that stimulates the body’s own immune defenses is safe to give to prostate cancer patients early in the disease’s progression, a recent study found.
Researchers have developed a personalized genetic test that can accurately predict the risk for recurrence in prostate cancer patients.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$